SCHEMBL12412992

SCHEMBL12412992

Cc1ccc(-n2c3cc(C)ccc3c3oc4c5cc6oc7c(oc8c9ccc(C)cc9n(-c9ccc(C)cc9)c87)c6cc5oc4c32)cc1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.34
HTT P42858 2/20 0.34
KDM4E B2RXH2 2/20 0.34
PPARG P37231 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
NR2E3 Q9Y5X4 1/20 0.34
NCOR2 Q9Y618 1/20 0.34
MAOB P27338 4/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12413047 0.94 MAOB (0.33) ALDH1A1HTTKDM4EPPARGNPSR1
SCHEMBL12412942 0.90 ALDH1A1 (0.36) ALDH1A1HTTKDM4EPPARGNPSR1
SCHEMBL12504757 0.89 HTT (0.36) HTTKDM4EGAAMEN1KMT2A
SCHEMBL12413034 0.85 MAOB (0.35) ALDH1A1HTTKDM4EPPARGNPSR1
SCHEMBL12412913 0.85
SCHEMBL12412943 0.81 MAOB (0.39) ALDH1A1HTTKDM4EPPARGNPSR1
SCHEMBL12412997 0.81 ALDH1A1 (0.35) ALDH1A1HTTKDM4ENPSR1RXFP1
SCHEMBL12413059 0.81 THRB (0.32) ALDH1A1HTTKDM4EPPARGNPSR1
SCHEMBL12413175 0.81 MAOB (0.36) ALDH1A1HTTKDM4EPPARGNPSR1
SCHEMBL12503795 0.80 HTT (0.39) ALDH1A1HTTKDM4EPPARGNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166362-A1 NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166362-A1 NOVEL COMPOUND AND ORGANIC SEMICONDUCTOR MATERIAL SCLY, MSRB3, SOD1 ALDH1A1 2760/4885HTT 4130/4885KDM4E 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.